Medically reviewed
Are Peptides Legal? A Multi-Market Guide (US, UK, Australia)
James MitchellMSc Biochemistry 4 min read
The Short Answer
The legal status of peptides depends on which peptide, which country, and how it is being used. There is no single answer — legality varies significantly across jurisdictions and individual substances.
In general:
- Some peptides are freely available (GHK-Cu in topical products)
- Some require a prescription (most therapeutic peptides in Australia)
- Some exist in a regulatory grey area (many peptides in the US and UK)
- Some are banned in specific contexts (WADA-prohibited peptides for athletes)
United States
FDA Regulation
The FDA does not “approve” or “ban” peptides as a blanket category. Instead, individual peptides are regulated based on their intended use:
- FDA-approved peptide drugs: Some peptides are approved as pharmaceutical drugs (e.g., certain GLP-1 receptor agonists). These are legal with a prescription.
- Compounded peptides: Under Section 503A and 503B of the FD&C Act, compounding pharmacies may prepare peptide formulations that are not commercially available. This is the primary access channel for most therapeutic peptides.
- Research chemicals: Peptides sold “for research purposes only” exist in a legal grey area. They are not approved for human use but are not explicitly illegal to purchase.
The 2024-2026 Reclassification
The FDA has been categorising compounding peptides into Category 1 (restricted) and Category 2 (under evaluation). See our detailed guide to the FDA reclassification for current status.
Key Points for US Residents
- Most therapeutic peptides require a prescription from a licensed provider
- Compounding pharmacies operating under 503A/503B can legally prepare peptides
- “Research use only” peptides are not approved for self-administration
- State laws may impose additional restrictions
- Athletes subject to drug testing should check WADA and USADA guidelines
United Kingdom
MHRA Regulation
In the UK, peptides are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) under the Human Medicines Regulations 2012.
- Licensed medicines: Very few peptides are licensed as medicines in the UK. Those that are require a prescription.
- Unlicensed substances: Most peptides discussed in the peptide therapy community are not licensed by the MHRA. This means they cannot be legally sold for human consumption.
- Research chemicals: Peptides may be legally sold and purchased as research chemicals, provided they are not marketed for human use.
- Personal importation: UK law permits individuals to import medicines for personal use in limited quantities, subject to certain conditions.
Key Points for UK Residents
- Most therapeutic peptides are not MHRA-licensed
- Purchasing peptides “for research” is generally legal
- Self-administering unlicensed substances carries legal and health risks
- No NHS prescriptions available for most peptides
- The Misuse of Drugs Act does not currently classify most peptides as controlled substances
Australia
TGA Regulation
Australia has one of the more structured regulatory frameworks for peptides, administered by the Therapeutic Goods Administration (TGA).
- Scheduled substances: Many peptides are classified under Schedule 4 (Prescription Only Medicine) of the Poisons Standard. This means they can only be legally obtained with a prescription from an authorised prescriber.
- TGA-registered products: Some peptides (like AOD-9604) have achieved various levels of TGA recognition.
- Authorised Prescriber Scheme: Under the TGA’s Authorised Prescriber scheme, doctors can prescribe unapproved therapeutic goods (including certain peptides) to specific patients after obtaining approval.
- Special Access Scheme (SAS): Individual patients can access unapproved goods through SAS applications made by their doctor.
- Personal importation: The TGA permits personal importation of medicines in certain circumstances, though peptides may be subject to additional scrutiny.
Key Points for Australian Residents
- Most therapeutic peptides require a prescription
- The TGA Authorised Prescriber scheme is the primary legal access pathway
- Compounding pharmacies operate under TGA and state pharmacy board oversight
- Personal importation is possible but regulated
- ATAGI and sports bodies impose additional restrictions for athletes
WADA and Sports
The World Anti-Doping Agency (WADA) prohibits numerous peptides in competitive sport:
- S0 — Non-approved substances: Any substance not approved for human therapeutic use is prohibited (this captures most peptides)
- S2 — Peptide hormones, growth factors: Specific prohibitions on GH secretagogues (CJC-1295, Ipamorelin), GH fragments (AOD-9604), and related substances
- BPC-157 and TB-500: Prohibited under S0 as non-approved substances
Athletes subject to WADA, USADA, UKAD, or ASADA testing should assume most peptides are prohibited unless specifically confirmed otherwise.
Summary Table
| Peptide | US | UK | AU | WADA |
|---|---|---|---|---|
| BPC-157 | Grey area (Cat. 2) | Research only | Prescription | Banned |
| TB-500 | Grey area (Cat. 2) | Research only | Prescription | Banned |
| CJC-1295 | Grey area (Cat. 2) | Research only | Prescription | Banned |
| GHK-Cu (topical) | Legal OTC | Legal OTC | Legal OTC | Not listed |
| AOD-9604 | Grey area | Research only | Prescription | Banned |
| Thymosin Alpha-1 | Grey area (Cat. 2) | Research only | Prescription (SAS) | Not listed |
Staying Informed
Peptide regulations are evolving rapidly. We update our Regulatory Tracker monthly with the latest status changes across all jurisdictions.
For a comprehensive offline reference, see our 2026 Peptide Legality Guide.